Company

Cancer’s Vulnerability is Our Strength

MANAGEMENT

Markus Renschler, MD
Markus Renschler, MDPresident & Chief Executive Officer
Adam Veness, Esq.
Adam Veness, Esq.General Counsel
Judson Englert, MD, PhD
Judson Englert, MD, PhDSVP, Clinical Research & Development
Jean-Marc Lapierre, PhD
Jean-Marc Lapierre, PhDSVP, Chemistry
Andrew Gengos
Andrew GengosChief Business Officer
Gale Cohen
Gale CohenVP, Human Resources
David Gaiero
David GaieroVP, Finance
Krisztina Nemenyi, PhD, RAC
Krisztina Nemenyi, PhD, RACSVP, Regulatory Affairs and Quality
Paul Secrist, PhD
Paul Secrist, PhDChief Scientific Officer
Susan Doleman
Susan DolemanVP, Clinical Operations
Lisa Hayes
Lisa HayesVP, Investor Relations and Corporate Communications
Tom O'Shea, PhD
Tom O'Shea, PhDSVP, Clinical Pharmacology and Preclinical Development

BOARD OF DIRECTORS

Joseph S. Zakrzewski
Joseph S. ZakrzewskiIndependent Investor & Chairman, Cyteir Therapeutics
Jeffrey Humphrey, MD
Jeffrey Humphrey, MDMagenta Therapeutics
Timothy Romberger
Timothy RombergerFounder Cyteir Therapeutics & TRC Advisory
Racquel Bracken
Racquel BrackenVenrock
Susan Molineaux, PhD
Susan Molineaux, PhDPresident and CEO of Calithera Biosciences
Stephen Sands
Stephen SandsVice Chairman Investment Banking and Chairman of Global Healthcare Group, Lazard
Jean George, MBA
Jean George, MBALightstone Ventures
Markus Renschler, MD
Markus Renschler, MDPresident & Chief Executive Officer
John Thero
John TheroBoard of Directors at CinCor Pharma